AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Other Current Assets

Current assets not reported separately, such as prepaid expenses.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Other Current Assets · Q3 FY2025 · quarter ended Sep 2025

Other current assets of €3.43M in Q3 FY2025

Q3 FY2025 other current assets was €3.43M.

Context

  • Other current assets amounted to 2.1% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€3.43M— QoQ
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Assets history

Currency unavailable · from the balance sheet

No Other Current Assets data reported for this period type.

Other Current Assets vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
  • Other current assets amounts to 2.1% of total assets for AGMB, versus a peer median of 1.3%.
AGMB Competitors
Other Current Assets for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$7.93M USD-66.1%+233.6%1.4%
ANABAnaptysBio, Inc.Mar 2026$3.91M USD-26.2%+1.6%1.2%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€3.43M EUR——2.1%
EQEquillium, Inc.Mar 2026$953K USD+2547.2%—1.5%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD-100.0%+59.8%0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-46.1%+59.8%1.3%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.